Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  2015-07-10

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1007/s13318-015-0290-5PMID 26156887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs – a case study with valsartan

  2015cited by this paper
• Solubility enhancement using poly(meth)acrylate based solid dispersions

  2015cited by this paper
• Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.

  2014cited by this paper
• Ocular delivery of flurbiprofen based on Eudragit(®) E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation.

  2014cited by this paper
• The release behavior and kinetic evaluation of tramadol HCl from chemically cross linked Ter polymeric hydrogels

  2013cited by this paper
• pH- and ion-sensitive polymers for drug delivery

  2013cited by this paper
• Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(ϵ-caprolactone) films

  2013cited by this paper
• Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state.

  2013cited by this paper
• Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs

  2012cited by this paper
• Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.

  2012cited by this paper
• Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment

  2011cited by this paper
• Characterization of Olanzapine-Solid Dispersions

  2011cited by this paper
• Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action

  2011cited by this paper
• Kinetic modeling on drug release from controlled drug delivery systems.

  2010cited by this paper
• Preparation and Evaluation of Ethyl Cellulose Microspheres Containing Diclofenac Sodium by Novel W/O/O Emulsion Method

  2010cited by this paper
• Physicochemical Properties of Solid Dispersions of Gliclazide in Polyvinylpyrrolidone K90

  2009cited by this paper
• Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100.

  2008cited by this paper
• Current Methods for Predicting Human Food Effect

  2008cited by this paper
• HPLC Sample Preparation

  2008cited by this paper
• Enhancing intestinal drug solubilisation using lipid-based delivery systems.

  2008cited by this paper
• 8 HPLC sample preparation

  2007cited by this paper
• Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.

  2007cited by this paper
• Development of prednisone: Polyethylene glycol 6000 fast-release tablets from solid dispersions: Solid-state characterization, dissolution behavior, and formulation parameters

  2007cited by this paper
• Predicting Effect of Food on Extent of Drug Absorption Based on Physicochemical Properties

  2007cited by this paper
• Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate.

  2006cited by this paper
• Physicochemical Characterization of Solid Dispersions of Indomethacin with PEG 6000, Myrj 52, Lactose, Sorbitol, Dextrin, and Eudragit® E100

  2004cited by this paper
• High performance liquid chromatographic determination of glucosamine in rat plasma.

  2002cited by this paper
• Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

  1999cited by this paper
• Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique.

  1999cited by this paper
• Valsartan in heart failure patients previously untreated with an ACE inhibitor.

  1998cited by this paper
• Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.

  1997cited by this paper
• Pharmaceutical applications of solid dispersion systems: dissolution of griseofulvin-succinic acid eutectic mixture.

  1976cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper

• Design and Optimization of Inclusion Complexes Using QbD Principles: A Strategy To Enhance Solubility and Dissolution of Voriconazole

  2025cites this paper
• Fabrication and Optimization of Valsartan-loaded Transbilosomes for Management of Diabetes Mellitus-accelerated Stroke.

  2025cites this paper
• Valsartan – Choline: Preparation, Characterization, and transdermal permeation

  2025cites this paper
• Co-delivery of novel valsartan and hydrochlorothiazide pH-responsive electrospun polymeric nanofibers for improved oral delivery

  2024cites this paper
• Drug Solubility Enhancement Strategies Using Amorphous Solid Dispersion: Examination on Type and The Amount of the Polymer

  2024cites this paper
• Enhancement of Valsartan Solubility by Amorphous solid Dispersion Ternary System: An Optimization and Characterization

  2024cites this paper
• Optimizing Nateglinide Liquisolid Compacts: Achieving Formulation Excellence Through the Quality by Design Approach

  2024cites this paper
• Enhancement of dissolution rate of racecadotril by liquisolid compact technology

  2022cites this paper
• Preparation and in vitro characterization of valsartan-loaded ethyl cellulose and poly(methyl methacrylate) nanoparticles

  2020cites this paper
• Candesartan Cilexetil In Vitro–In Vivo Correlation: Predictive Dissolution as a Development Tool

  2020cites this paper
• Co amorphous valsartan nifedipine system: Preparation, characterization, in vitro and in vivo evaluation.

  2019cites this paper
• Mechanistic investigation on the performance of Huperzine A loaded microparticles based on ultra-fine particle processing system

  2018cites this paper
• Solubility and dissolution enhancement of flurbiprofen by solid dispersion using hydrophilic carriers

  2018cites this paper
• Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro‐in silico approach

  2018cites this paper
• Formation Mechanism and In Vitro Evaluation of Risperidone-Containing PLGA Microspheres Fabricated by Ultrafine Particle Processing System.

  2017cites this paper
• Développement de formulations polymériques de S-nitrosoglutathion comme traitement per os pour prévenir les maladies inflammatoires chroniques de l’intestin

  2017cites this paper
• Formulation Development and Evaluation of Sustained Release Bioadhesive Bilayered Buccal Tablets of Furosemide

  2017cites this paper
• Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms

  2017cites this paper